Insmed Incorporated
INSM
$72.65
$2.453.49%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -6.81% | 26.64% | -91.36% | 15.57% | -17.07% |
| Total Depreciation and Amortization | 0.91% | 1.06% | -6.60% | 5.13% | -0.77% |
| Total Amortization of Deferred Charges | 9.71% | -10.45% | -1.63% | 3.34% | -2.92% |
| Total Other Non-Cash Items | -87.55% | -62.04% | 482.85% | -46.22% | 2.69% |
| Change in Net Operating Assets | 278.77% | -139.76% | 171.76% | -818.76% | 132.00% |
| Cash from Operations | -8.33% | -47.14% | 33.19% | -40.68% | 4.04% |
| Capital Expenditure | -83.57% | 45.61% | -44.97% | -117.32% | 24.56% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 113.86% | -- | -100.00% | 7,483.42% | -60.44% |
| Cash from Investing | 113.13% | -14,693.91% | -102.30% | 16,279.42% | -74.77% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -4.26% | -2.02% | -3.86% | -153.26% | 206.78% |
| Issuance of Common Stock | -96.55% | -49.11% | 19,192.42% | -96.68% | 5,115.59% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 200.00% | -- | -- |
| Cash from Financing | -59.89% | -49.17% | 25,760.13% | -97.55% | 9,768.94% |
| Foreign Exchange rate Adjustments | -181.84% | 367.30% | 27.81% | -193.98% | -53.23% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 111.92% | -220.62% | 474.36% | 2,491.96% | 96.23% |